Age-adjusted prevalence ratios for hyperglycemia defined by ADA and WHO using standard and data-derived cut-offs for generalized and abdominal obesity
| Prevalence ratio (95% CI) | ||
| Women | Men | |
| Generalized obesity | ||
| BMI ≥25 kg/m2 | ||
| ADA-defined hyperglycemia | 1.3 (1.1 to 1.6) | 1.3 (1.0 to 1.7) |
| WHO-defined hyperglycemia | 1.9 (1.3 to 2.9) | 1.5 (0.9 to 2.4) |
| BMI ≥30 kg/m2 | ||
| ADA-defined hyperglycemia | 1.2 (1.0 to 1.4) | 1.4 (1.2 to 1.7) |
| WHO-defined hyperglycemia | 1.7 (1.2 to 2.2) | 1.6 (1.1 to 2.2) |
| Data-derived | ||
| ADA-defined hyperglycemia | 1.2 (1.1 to 1.4) | 1.5 (1.1 to 1.9) |
| WHO-defined hyperglycemia | 1.7 (1.3 to 2.3) | 1.8 (1.1 to 3.1) |
| Abdominal obesity | ||
| IDF criteria | ||
| ADA-defined hyperglycemia | 1.8 (1.3 to 2.4) | 1.4 (1.1 to 1.7) |
| WHO-defined hyperglycemia | 2.9 (1.6 to 5.2) | 1.6 (1.1 to 2.3) |
| AHA/NHLBI criteria | ||
| ADA-defined hyperglycemia | 1.4 (1.2 to 1.7) | 1.3 (1.1 to 1.7) |
| WHO-defined hyperglycemia | 2.4 (1.5 to 3.6) | 1.6 (1.1 to 2.4) |
| Data-derived | ||
| ADA-defined hyperglycemia | 1.5 (1.2 to 1.8) | 1.7 (1.2 to 2.3) |
| WHO-defined hyperglycemia | 2.8 (1.9 to 4.2) | 2.7 (1.6 to 4.5) |
ADA, American Diabetes Association; AHA, American Heart Association; BMI, body mass index; IDF, International Diabetes Federation; NHLBI, National Heart, Lung, and Blood Institute; WHO, World Health Organization.